Cannabinoids, mostly CBD, have already been examined for the therapy of seizures associated with varieties of epilepsy which can be difficult to Handle with other medicines. Epidiolex (oral CBD) continues to be permitted via the FDA with the therapy of seizures related to two epileptic encephalopathies: Lennox-Gastaut syndrome and Dravet syndrome.L